Market Snapshot

S&P Futures
4,136.25
Dow Futures
33,817.00
NASDAQ Futures
13,838.50

Why Teligent, Inc. (TLGT) stock is falling today?

Related Topics

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Shares of Teligent, Inc. (TLGT) stock were down today after rising  12.52% in the last trading session. TLGT stock price saw a downtrend of  4.27% to drop at  $0.6725 a share at the time of this writing. Let’s deep dive to understand the reason behind this fall.

What’s happening?

Teligent, Inc. is a pharmaceutical company working on the development, manufacturing, marketing, and selling of a variety of pharmaceutical products in the United States and Canada. There is no Teligent specific news to explain the reason behind this fall today. Even we find no news, earnings report, analyst downgrades, or shrank targeted per share price in the whole of March to connect with this fall. This is spreading curiosity among investors who are eager to hear some specific related to TLGT stock. So, it is better to look at some previous recent events of Teligent.

February 2021 Events:

Teligent, in February 2021, announced the new appointments in a couple of its management positions. On February 23, 2021, TLGT appointed Carter Pate to its Board of Directors. Mr. Pate is serving on the Board of Directors at various other companies and currently holding the responsibilities of Audit and Nominating and Corporate Governance Committees in Teligent.

On February 16, 2021, William S. Marth, an industry expert, joined Teligent as a member of its Board of Directors. Mr. Marth has experience of 25 years in the pharmaceutical companies as well as manufacturing industries.

Financial View of TLGT stock:

  • According to the third-quarter results, TLGT stock generated 14.3 million revenue which was 6% higher than the previous quarter due to the high demand for topical products in the U.S.Gross profit of TLGT stock reduced to $0.1 million from $2.4 million in the second quarter of 2020 due to additional expenses related to inventory reserves and other write-offs.
  • Product development and research expenses surged to $2.4 million while selling, general and administrative expenses were $6.5 million in the third quarter of 2020.
  • Operating losses in the third quarter were $8.8 million while the $0.5 million net loss is observed in the third quarter of 2020.

Conclusion:

Things are going against the TLGT stock as far as market sentiment is concerned. It seems that momentum was built in the previous trading session but such rises don’t last for a long time.COVID-19 was a major challenge in the continuity of Telligent’s operations, but the management has performed well over the past year. In a nutshell, it would be better for investors to analyze the nitty-gritty of the TLGT stock before taking any decision.

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:
Sign up for our FREE Newsletter and get:

SOCIAL LINKS

Latest Posts